FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to a complex for editing the genome of a mouse egg cell based on CRISPR/Cas9, consisting of mRNA of the S. using. Also disclosed is a mouse strain with a humanized nucleotide sequence of exon 6 of the Gnao1 gene.
EFFECT: invention is effective for in vivo testing of the specificity of RNA therapy drugs for patients with variant c.607 G>A GNAO1 encephalopathy.
4 cl, 6 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
PDE6B GENE KNOCKOUT MOUSE MODEL CREATING AND APPLYING METHOD | 2022 |
|
RU2791687C1 |
CRISPR-CAS SYSTEM COMPONENTS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | 2013 |
|
RU2701662C2 |
METHOD FOR EDITING THE GJB2 GENE TO CORRECT THE PATHOGENIC VARIANT OF c.del35G IN HUMAN CELLS CULTURED IN VITRO | 2021 |
|
RU2780677C1 |
RNA-GUIDED ENGINEERING OF HUMAN GENOME | 2013 |
|
RU2699523C2 |
METHOD OF PRODUCING GENETICALLY MODIFIED MICE EXPRESSING HUMAN ANTITHROMBIN III MINIGENE USING MICROINJECTIONS OF TELN-LINEARIZED DNA FRAGMENT | 2022 |
|
RU2806568C1 |
METHOD FOR OBTAINING WHEAT PLANT WITH NUCLEOTIDE DELETION IN PROMOTOR REGION OF VRN-A1 GENE USING CRISPR/CAS9 TECHNOLOGY OF PLANT GENOME EDITING | 2020 |
|
RU2772577C2 |
GENOMIC ENGINEERING | 2014 |
|
RU2688462C2 |
METHOD FOR PRODUCING A WHEAT PLANT WITH A NUCLEOTIDE INSERT IN THE PROMOTOR REGION OF THE VRN-A1 GENE USING THE CRISPR/CAS9 TECHNOLOGY FOR EDITING PLANT GENOME | 2020 |
|
RU2772578C2 |
RNA-GUIDED HUMAN GENOME ENGINEERING | 2013 |
|
RU2766685C2 |
METHOD FOR CONSTRUCTING MAMMALIAN MINIGENES AND RECOMBINANT PLASMID PGC1HDR ENCODING THE HUMAN C1 ESTERASE INHIBITOR MINIGENE INTENDED FOR PRODUCING MICE HUMANIZED BY THE SERPING1 GENE | 2022 |
|
RU2805177C1 |
Authors
Dates
2021-10-11—Published
2021-06-02—Filed